Equigerminal is a certified R&D biotech company based in Penela, Portugal, focused on advancing animal health and One Health integration through science, technology, and ethics. We develop genetic, molecular and digital tools for preventive and precision veterinary medicine — from our diagnostic platforms to our digital twin ecosystem (CIICOH) and the AI-powered health assistant (AImals). We believe in science with soul, and in co-creating a future where animals live longer, healthier lives alongside humans — guided by ethics, innovation and data. Join us as we build the next chapter in veterinary biotechnology and integrative intelligence.
Looking for a particular Equigerminal employee's phone or email?
The Equigerminal annual revenue was $1 million in 2026.
Isabel Fidalgo Carvalho is the Co-founder and CEO, EQUIGERMINAL, S.A. of Equigerminal.
2 people are employed at Equigerminal.
Equigerminal is based in Coimbra, Coimbra.
The NAICS codes for Equigerminal are [62151, 6215, 62, 621].
The SIC codes for Equigerminal are [807, 80].